Literature DB >> 12553067

The role of proteolysis in tumor invasiveness in glioblastoma and metastatic brain tumors.

Masaaki Yamamoto1, Yushi Ueno, Shuji Hayashi, Takeo Fukushima.   

Abstract

Local invasive infiltration and growth are key features in glioblastoma, which are accompanied by remodeling of the vasculature and the destruction of the surrounding normal brain tissues. The local and regional spread of glioblastoma is often associated with poor prognosis. The invasive character of glioblastoma appears to depend partly on the proteolytic destruction of the extracellular matrix components. In this article, we review the role of proteolytic enzymes, urokinase-type plasminogen activator and matrix-metalloproteases, for diffuse infiltrative growth of glioblastoma. An understanding of the mechanisms of increased expression of these molecules in glioblastoma might provide an insight into the regulatory pathway of cellular invasion and for a new therapeutic strategy for glioblastoma.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12553067

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  15 in total

1.  RNA interference-mediated simultaneous down-regulation of urokinase-type plasminogen activator receptor and cathepsin B induces caspase-8-mediated apoptosis in SNB19 human glioma cells.

Authors:  Christopher S Gondi; Neelima Kandhukuri; Shakuntala Kondraganti; Meena Gujrati; William C Olivero; Dzung H Dinh; Jasti S Rao
Journal:  Mol Cancer Ther       Date:  2006-12       Impact factor: 6.261

2.  Glioblastoma on a microfluidic chip: Generating pseudopalisades and enhancing aggressiveness through blood vessel obstruction events.

Authors:  Jose M Ayuso; Rosa Monge; Alicia Martínez-González; María Virumbrales-Muñoz; Guillermo A Llamazares; Javier Berganzo; Aurelio Hernández-Laín; Jorge Santolaria; Manuel Doblaré; Christopher Hubert; Jeremy N Rich; Pilar Sánchez-Gómez; Víctor M Pérez-García; Ignacio Ochoa; Luis J Fernández
Journal:  Neuro Oncol       Date:  2017-04-01       Impact factor: 12.300

3.  Glioblastoma cells vampirize WNT from neurons and trigger a JNK/MMP signaling loop that enhances glioblastoma progression and neurodegeneration.

Authors:  Marta Portela; Varun Venkataramani; Natasha Fahey-Lozano; Esther Seco; Maria Losada-Perez; Frank Winkler; Sergio Casas-Tintó
Journal:  PLoS Biol       Date:  2019-12-17       Impact factor: 8.029

4.  NPAS3 demonstrates features of a tumor suppressive role in driving the progression of Astrocytomas.

Authors:  Frederico Moreira; Tim-Rasmus Kiehl; Kelvin So; Norbert F Ajeawung; Carmelita Honculada; Peter Gould; Russell O Pieper; Deepak Kamnasaran
Journal:  Am J Pathol       Date:  2011-05-19       Impact factor: 4.307

Review 5.  Pathobiology of brain metastases.

Authors:  N Nathoo; A Chahlavi; G H Barnett; S A Toms
Journal:  J Clin Pathol       Date:  2005-03       Impact factor: 3.411

6.  Tristetraprolin inhibits the growth of human glioma cells through downregulation of urokinase plasminogen activator/urokinase plasminogen activator receptor mRNAs.

Authors:  Jinhyun Ryu; Nal Ae Yoon; Yeon Kyung Lee; Joo Yeon Jeong; Seokmin Kang; Hyemin Seong; Jungil Choi; Nammi Park; Nayoung Kim; Wha Ja Cho; Sun Ha Paek; Gyeong Jae Cho; Wan Sung Choi; Jae-Yong Park; Jeong Woo Park; Sang Soo Kang
Journal:  Mol Cells       Date:  2014-12-30       Impact factor: 5.034

7.  Inhibition of matrix degrading enzymes and invasion in human glioblastoma (U87MG) cells by isoflavones.

Authors:  Shilpa Puli; James C K Lai; Alok Bhushan
Journal:  J Neurooncol       Date:  2006-04-06       Impact factor: 4.130

8.  The invasiveness of five medulloblastoma cell lines in collagen gels.

Authors:  Adrianna Ranger; Warren McDonald; Emi Moore; Rolando Delmaestro
Journal:  J Neurooncol       Date:  2009-07-15       Impact factor: 4.130

9.  Correlation between metastatic potential and variants from colorectal tumor cell line HT-29.

Authors:  Min Wang; Ilka Vogel; Holger Kalthoff
Journal:  World J Gastroenterol       Date:  2003-11       Impact factor: 5.742

Review 10.  Targeted toxins in brain tumor therapy.

Authors:  Yan Michael Li; Walter A Hall
Journal:  Toxins (Basel)       Date:  2010-11-01       Impact factor: 5.075

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.